Name: Management of Medication-Related Osteonecrosis of the Jaw: An Issue of Oral and Maxillofacial Clinics of North America: Vol 27 (en Inglés)
Price: 92.35 USD
Availability: InStock
Author: Salvatore L. Ruggiero Dmd Md Facs
ISBN: 9780323413466

portada Management of Medication-Related Osteonecrosis of the Jaw: An Issue of Oral and Maxillofacial Clinics of North America: Vol 27 (en Inglés)

Formato

Libro Físico

Editorial

Elsevier - Health Sciences Division,

Autor

Salvatore L. Ruggiero Dmd Md Facs

Idioma

Inglés

Encuadernación

Tapa Dura

ISBN13

9780323413466

Management of Medication-Related Osteonecrosis of the Jaw: An Issue of Oral and Maxillofacial Clinics of North America: Vol 27 (en Inglés)

Salvatore L. Ruggiero Dmd Md Facs (Autor) · Elsevier - Health Sciences Division, · Tapa Dura

Libro Nuevo

$ 92.35

$ 153.91

Ahorras: $ 61.56

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 23 de Julio y el Viernes 02 de Agosto.

Lo recibirás en cualquier lugar de Internacional entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Management of Medication-Related Osteonecrosis of the Jaw: An Issue of Oral and Maxillofacial Clinics of North America: Vol 27 (en Inglés)"

Editor Salvatore Ruggiero, DMD, MD and authors review the Diagnosis, Management and Prevention of Medication-related Osteonecrosis of the Jaw. Articles will include: Osteoporosis and bone modulation therapies: indications and outcomes; Antiresorptive therapies for the treatment of malignant osteolytic bone disease; Clinical presentation and staging of antiresorptive agent-induced osteonecrosis of the jaw; Epidemiology and risk factors of antiresorptive agent-induced osteonecrosis of the jaw; Basic science research of antiresorptive agent-induced osteonecrosis of the jaw: an update; Pathophysiology of antiresorptive agent-induced osteonecrosis of the jaw: what we know and what we don't know; The genetics of osteonecrosis of the jaw; Preventive strategies for patients at risk of antiresorptive agent-induced osteonecrosis of the jaw; Non-operative and operative therapies for treatment of antiresorptive agent-induced osteonecrosis of the jaw; The role of anti-angiogenic therapy in the development of osteonecrosis of the jaw; Antiresorptive therapies: what they are and how do they work, and more!